January 17, 2025 Current Events 0 Comments CMS comes out with List of Drugs for 2027 Price Negotiation – Healthcare Economist From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial PriceApplicability Year 2027“: On January 17, ... Read More
January 8, 2025 Economics - General 0 Comments Life sciences companies falling behind? – Healthcare Economist That is what an analysis from PwC finds, at least with respect to stock market returns. Our PwC equal-weight ... Read More
December 19, 2024 FDA 0 Comments Evolution of orphan drug – Healthcare Economist A study by Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug ... Read More
December 11, 2024 Biosimilar 0 Comments How many patients are switching to biosimilars? – Healthcare Economist That is a key question if long-run drug prices are going to come down for biologic products. We can ... Read More
October 20, 2024 Employee Benefits 0 Comments ‘Employers Haven’t a Clue How Their Drug Benefits Are Managed’ – Healthcare Economist That is the title of a KFF article published last week. The results are based on KFF’s 2024 Employer ... Read More
September 16, 2024 Cost plus 0 Comments Why is the market design for innovative pharmaceuticals not well understood? – Healthcare Economist That is the title of a fantastic editorial from Olivença et al. (2024). A lot of people when they look at pharmaceutical prices think ... Read More
August 21, 2024 Dynamic cost-effectiveness 0 Comments Impact of genericization on drug prices and treatment value across 8 countries – Healthcare Economist An interesting study from Miquel Serra-Burriel et al. (2024) examines the impact of genericization on drug prices across 8 ... Read More
August 15, 2024 Current Events 0 Comments Medicare Drug Price Negotiation leads to 38% to 79% price decrease – Healthcare Economist Medicare drug price negotiation is here. The maximum fair prices (MFP) set by Medicare lead to discounts between 38% and 79%. In fact, the ... Read More
July 16, 2024 FTC 0 Comments FTC report on PBMs – Healthcare Economist Last week, the Federal Trade Commission (FTC) released a report titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug ... Read More
July 5, 2024 CPI 0 Comments How would the inclusion of specialty drugs impact CPI-Rx? – Healthcare Economist The Bureau of Labor Statistics’ (BLS’) Prescription Drug Consumer Price Index (CPI‐Rx) looks at price changes for drugs dispensed at outpatient retail pharmacies. However, ... Read More